A. W. Dekker

4.0k total citations
66 papers, 3.0k citations indexed

About

A. W. Dekker is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, A. W. Dekker has authored 66 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hematology, 29 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in A. W. Dekker's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (16 papers) and Neutropenia and Cancer Infections (14 papers). A. W. Dekker is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (16 papers) and Neutropenia and Cancer Infections (14 papers). A. W. Dekker collaborates with scholars based in Netherlands, Belgium and United Kingdom. A. W. Dekker's co-authors include Leo F. Verdonck, Bob Löwenberg, Pieter Sonneveld, M. Rozenberg-Arska, H M Lokhorst, J. Verhoef, Harry C. Schouten, K. Punt, Jan J. Cornelissen and O J Meuwissen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

A. W. Dekker

65 papers receiving 2.9k citations

Peers

A. W. Dekker

HEMAT

ONCOL

PHEOH

EPIDE

William P. Vaughan United States

Simon Daenen Netherlands

Lourdes Vázquez Spain

Michael Kiehl Germany

Sébastien Maury France

Finn Bo Petersen United States

Anna Candoni Italy

R. De Bock Belgium

Dick Stockelberg Sweden

H. Gary Schoch United States

William P. Vaughan United States

A. W. Dekker

1.0k ×0.7

HEMAT

868 ×0.7

ONCOL

359 ×0.5

PHEOH

408 ×0.6

EPIDE

364 ×0.7

Citations per year, relative to A. W. Dekker A. W. Dekker (= 1×) peers William P. Vaughan

Countries citing papers authored by A. W. Dekker

Since Specialization

Citations

This map shows the geographic impact of A. W. Dekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. W. Dekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. W. Dekker more than expected).

Fields of papers citing papers by A. W. Dekker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. W. Dekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. W. Dekker. The network helps show where A. W. Dekker may publish in the future.

Co-authorship network of co-authors of A. W. Dekker

This figure shows the co-authorship network connecting the top 25 collaborators of A. W. Dekker. A scholar is included among the top collaborators of A. W. Dekker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. W. Dekker. A. W. Dekker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Percy, Melanie J., Paul W. Furlow, Philip Beer, et al.. (2009). Erythropoietin synthesis is primarily regulated by the PHD2-HIF-2alpha-VHL axis as documented by HIF-2alpha associated familial erythrocytosis. British Journal of Haematology. 145. 44–45.

Cornelissen, Jan J., Bronno van der Holt, Gregor Verhoef, et al.. (2008). Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood. 113(6). 1375–1382. 121 indexed citations

Top, Janetta, Hetty E. M. Blok, Titia E. M. Hopmans, et al.. (2008). High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital. Journal of Antimicrobial Chemotherapy. 62(6). 1401–1406. 42 indexed citations

Breems, Dimitri, Marc Boogaerts, A. W. Dekker, et al.. (2004). Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato‐Oncology Co‐operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial. British Journal of Haematology. 128(1). 59–65. 57 indexed citations

Meijer, Ellen, A. W. Dekker, H M Lokhorst, et al.. (2004). Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation. Transplant Infectious Disease. 6(4). 171–178. 27 indexed citations

Meijer, Ellen, A. W. Dekker, & Leo F. Verdonck. (2003). Influence of antithymocyte globulin dose on outcome in cytomegalovirus‐seropositive recipients of partially T cell‐depleted stem cell grafts from matched‐unrelated donors. British Journal of Haematology. 121(3). 473–476. 11 indexed citations

Fijnheer, Rob, et al.. (2002). Factor V Leiden in central venous catheter‐associated thrombosis. British Journal of Haematology. 118(1). 267–270. 56 indexed citations

Straaten, Hanneke M., Rob Fijnheer, A. W. Dekker, H K Nieuwenhuis, & Leo F. Verdonck. (2001). Relationship between graft‐versus‐host disease and graft‐versus‐leukaemia in partial T cell‐depleted bone marrow transplantation. British Journal of Haematology. 114(1). 31–35. 8 indexed citations

Löwenberg, Bob, Stefan Suciu, E Archimbaud, et al.. (1998). Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.. Journal of Clinical Oncology. 16(3). 872–881. 218 indexed citations

10.

Lokhorst, Henk M., et al.. (1996). Intermediate‐dose melphalan (IDM) combined with G‐CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma. British Journal of Haematology. 92(1). 44–48. 20 indexed citations

11.

Verdonck, Leo F., Wim L.J. van Putten, Anton Hagenbeek, et al.. (1995). Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma. New England Journal of Medicine. 332(16). 1045–1051. 189 indexed citations

12.

Dekker, A. W., et al.. (1994). Treatment of localized non-Hodgkin's lymphomas of the head and neck. Cancer. 74(2). 703–707. 19 indexed citations

13.

Cornelissen, J.J., Pieter Sonneveld, M. Schoester, et al.. (1994). MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.. Journal of Clinical Oncology. 12(1). 115–119. 65 indexed citations

14.

Lokhorst, H M, O J Meuwissen, Leo F. Verdonck, & A. W. Dekker. (1992). High-risk multiple myeloma treated with high-dose melphalan.. Journal of Clinical Oncology. 10(1). 47–51. 43 indexed citations

15.

Loeliger, A, et al.. (1992). Hepatosplenic candidasis, a fatal disease?. Infection. 20(6). 336–338. 8 indexed citations

16.

Punt, Cornelis J.A., et al.. (1991). Partial characterization of protein tyrosine kinase activity in normal and leukemic human myeloid cells. Leukemia Research. 15(12). 1107–1116. 1 indexed citations

17.

Dekker, A. W., et al.. (1991). Prevention of Infections in Granulocytopenic Patients by Fluorinated Quinolones. Recent results in cancer research. 121. 337–346. 1 indexed citations

18.

Dekker, A. W., M. Rozenberg-Arska, & Leo F. Verdonck. (1990). Prevention of Bacteremias Caused by α-Hemolytic Streptococci by Roxithromycin in Patients Treated with Intensive Cytotoxic Treatment. Hämatologie und Bluttransfusion. 33. 551–554. 4 indexed citations

19.

Verhoef, J., M. Rozenberg-Arska, & A. W. Dekker. (1989). Prevention of bacterial and fungal infections in granulocytopenic patients. European Journal of Cancer and Clinical Oncology. 25(9). 1345–1350. 7 indexed citations

20.

Rozenberg-Arska, M. & A. W. Dekker. (1987). Ciprofloxacin for infection prevention in patients with acute leukemia. Pharmacy World & Science. 9(S1). S45–S47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact